ZMYM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.77395900588817E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.23570043086829E-10 |
Normal-vs-Stage2 |
5.78070036283407E-10 |
Normal-vs-Stage3 |
2.14417372745856E-12 |
Normal-vs-Stage4 |
6.38200603475525E-12 |
Stage1-vs-Stage2 |
7.132100E-02 |
Stage1-vs-Stage3 |
3.371600E-02 |
Stage1-vs-Stage4 |
5.922100E-02 |
Stage2-vs-Stage3 |
8.565400E-01 |
Stage2-vs-Stage4 |
8.385200E-01 |
Stage3-vs-Stage4 |
9.825800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6286971771251E-12 |
Normal-vs-AfricanAmerican |
5.6527000003026E-07 |
Normal-vs-Asian |
3.408400E-02 |
Caucasian-vs-AfricanAmerican |
7.038000E-01 |
Caucasian-vs-Asian |
6.959800E-03 |
AfricanAmerican-vs-Asian |
2.284300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.32747196252603E-15 |
Normal-vs-Female |
5.98999738699035E-11 |
Male-vs-Female |
4.501700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.51230000003488E-06 |
Normal-vs-Age(41-60Yrs) |
6.20290485642272E-11 |
Normal-vs-Age(61-80Yrs) |
1.63957736276643E-12 |
Normal-vs-Age(81-100Yrs) |
7.14779999966275E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.427000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.708800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.587600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.809000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.118400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.711000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.259600E-01 |
Normal-vs-Grade 2 |
3.1354030483044E-11 |
Normal-vs-Grade 3 |
1.88482562890613E-12 |
Normal-vs-Grade 4 |
2.2261081866759E-12 |
Grade 1-vs-Grade 2 |
1.188490E-02 |
Grade 1-vs-Grade 3 |
3.304800E-03 |
Grade 1-vs-Grade 4 |
1.976360E-04 |
Grade 2-vs-Grade 3 |
2.295000E-01 |
Grade 2-vs-Grade 4 |
3.857600E-02 |
Grade 3-vs-Grade 4 |
3.284400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63949964715471E-10 |
Normal-vs-ccB subtype |
4.58399984637481E-12 |
ccA subtype-vs-ccB subtype |
5.803900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.31470398404099E-11 |
Normal-vs-N1 |
1.221110E-04 |
N0-vs-N1 |
7.052200E-01 |
|
|